Vanda Pharmaceuticals
VNDA
#7861
Rank
A$0.47 B
Marketcap
A$8.11
Share price
3.65%
Change (1 day)
9.50%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2025 (TTM): -A$0.19 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are A$0.21 Billion. In 2024 the company made an earning of -A$61.22 Million a decrease over its 2023 earnings that were of -A$21.01 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$0.19 Billion207.3%
2024 -A$61.22 Million191.43%
2023 -A$21.01 Million-320.45%
2022 A$9.52 M-84.99%
2021 A$63.47 M54.8%
2020 A$41 M19.42%
2019 A$34.34 M4.93%
2018 A$32.72 M-228.6%
2017 -A$25.45 Million-8.98%
2016 -A$27.96 Million-53.79%
2015 -A$60.5 Million-30.18%
2014 -A$86.65 Million173.08%
2013 -A$31.73 Million-25.33%
2012 -A$42.5 Million163.61%
2011 -A$16.12 Million-221.15%
2010 A$13.3 M-124.53%
2009 -A$54.25 Million-29.44%
2008 -A$76.88 Million-36.2%
2007 -A$0.13 Billion21.81%
2006 -A$98.93 Million170.55%
2005 -A$36.57 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
A$24.71 B-13,658.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
A$33.87 B-18,683.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$48.77 B-26,852.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$12.09 B-6,733.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$17.84 B-9,887.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-A$4.23 Million-97.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$34.76 B-19,167.83%๐Ÿ‡บ๐Ÿ‡ธ USA